Skip to main content

AGIO Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Agios Pharmaceuticals Inc. News

Agios Soars on Plan to Sell Cancer Drugs, Return $1.2B to Holders

Drugmaker Agios soared on a plan to sell an oncology portfolio to Servier for up to $2 billion and return $1.2 billion to shareholders.

Celgene, Agios Update Blood Cancer Drug Study Results in ASCO '17 Abstract

The new enasidenib data -- improved tumor response rate but shorter duration -- were made public on Wednesday night in a research abstract.

4 Health Care Charts Signaling Buys: Pfizer, Amgen Included

Obamacare? Trumpcare? These stocks don't care.

These 4 Healthcare Charts Are Signaling Buys

Here's a rundown of four technical setups that are showing solid trading potential.

Biotechs Among 5 Stocks Setting Up for Major Breakouts

Here's how to rake in the profits off some potential big breakouts.

Breaking News

Morgan Stanley Stock Leads Gains As Banks Boost Dividends After Fed Stress Tests

Morgan Stanley, Wells Fargo, Bank of America and Goldman Sachs will lift their quarterly dividend, while JPMorgan will hold its steady following last week's Fed stress tests.

Nike Stock Slides As As Margin Pressures, China Worries Offset Q4 Earnings Beat

"We think we're well positioned for growth in fiscal year 2023 ... having said that, we did take a cautious approach to Greater China," said CFO Matthew Friend.

Playtika Stock Surges On Report of Joffre Capital Interest in Online Casino Gaming Group

Axios reported late Monday that tech buyout group Joffre Capital is seeking a majority stake in the online casino video game group.